Search Results

Eruptive Keratoacanthoma-Type Squamous Cell Carcinomas in Patients Taking Sorafenib for the Treatment of Solid Tumors

Authors: SMITH, KATHLEEN J.; HALEY, HEATHER; HAMZA, SATE; SKELTON, HENRY G.

Source: Dermatologic Surgery, Volume 35, Number 11, November 2009 , pp. 1766-1770(5)

Publisher: Blackwell Publishing

Targeting cell signalling pathways to fight the flu: towards a paradigm change in anti-influenza therapy

Author: Ludwig, Stephan

Source: Journal of Antimicrobial Chemotherapy, Volume 64, Number 1, 14 July 2009 , pp. 1-4(4)

Publisher: Oxford University Press

Sorafenib reveals efficacy in sequential treatment of metastatic renal cell cancer

Authors: Merseburger, Axel S; Simon, Annika; Waalkes, Sandra; Kuczyk, Markus A

Source: Expert Review of Anticancer Therapy, Volume 9, Number 10, October 2009 , pp. 1429-1434(6)

Publisher: Expert Reviews

Secreted phospholipase A₂-IIA modulates key regulators of proliferation on astrocytoma cells

Authors: Martín, Rubén; Hernández, Marita; Ibeas, Elvira; Fuentes, Lucia; Salicio, Veronica; Arnés, Mercedes; Nieto, María Luisa

Source: Journal of Neurochemistry, Volume 111, Number 4, November 2009 , pp. 988-999(12)

Publisher: Blackwell Publishing

Apoptosis and autophagy: BIM as a mediator of tumour cell death in response to oncogene-targeted therapeutics

Authors: Gillings, Annette S.; Balmanno, Kathryn; Wiggins, Ceri M.; Johnson, Mark; Cook, Simon J.

Source: FEBS Journal, Volume 276, Number 21, November 2009 , pp. 6050-6062(13)

Publisher: Blackwell Publishing

Disposition of GDC-0879, a B-RAF kinase inhibitor in preclinical species

Authors: Choo, E. F.; Driscoll, J. P.; Feng, J.; Liederer, B.; Plise, E.; Randolph, N.; Shin, Y.; Wong, S.; Ran, Y.

Source: Xenobiotica, Volume 39, Number 9, September 2009 , pp. 700-709(10)

Publisher: Informa Healthcare

Development of a novel chemical class of BRAF inhibitors offers new hope for melanoma treatment

Authors: Smalley, Keiran SM; Flaherty, Keith T

Source: Future Oncology, Volume 5, Number 6, August 2009 , pp. 775-778(4)

Publisher: Future Medicine

PrP^c activation induces neurite outgrowth and differentiation in PC12 cells: role for caveolin-1 in the signal transduction pathway

Authors: Pantera, Barbara; Bini, Chiara; Cirri, Paolo; Paoli, Paolo; Camici, Guido; Manao, Giampaolo; Caselli, Anna

Source: Journal of Neurochemistry, Volume 110, Number 1, July 2009 , pp. 194-207(14)

Publisher: Blackwell Publishing

Nitric oxide enhances expression of raf kinase inhibitor protein in keratinocytes

Authors: Tsao, Der-An; Yu, Hsin-Su; Chang, Huoy-Rou

Source: Experimental Dermatology, Volume 18, Number 6, June 2009 , pp. 571-573(3)

Publisher: Blackwell Publishing

Final analysis of a phase II trial using sorafenib for metastatic castration-resistant prostate cancer

Authors: Aragon-Ching, Jeanny B.; Jain, Lokesh; Gulley, James L.; Arlen, Philip M.; Wright, John J.; Steinberg, Seth M.; Draper, David; Venitz, Jürgen; Jones, Elizabeth; Chen, Clara C.; Figg, William D.; Dahut, William L.

Source: BJU International, Volume 103, Number 12, June 2009 , pp. 1636-1640(5)

Publisher: Blackwell Publishing

COMMON PATHWAYS FOR ACTIVATION OF PROINFLAMMATORY GENE EXPRESSION BY G PROTEIN-COUPLED RECEPTORS IN PRIMARY LUNG EPITHELIAL AND ENDOTHELIAL CELLS

Authors: Chang, Weiyuan; Chen, Jing; Schlueter, Connie; Hoyle, Gary

Source: Experimental Lung Research, Volume 35, Number 4, May 2009 , pp. 324-343(20)

Publisher: Informa Healthcare

Developmental Abnormalities and Cancer Predisposition in Neurofibromatosis Type 1

Authors: Larizza, Lidia; Gervasini, Cristina; Natacci, Federica; Riva, Paola

Source: Current Molecular Medicine, Volume 9, Number 5, June 2009 , pp. 634-653(20)

Publisher: Bentham Science Publishers

Signaling Intermediates (PI3K/PTEN/AKT/mTOR and RAF/MEK/ERK Pathways) as Therapeutic Targets for Anti-Cancer and Anti-Angiogenesis Treatments

Authors: Ciuffreda, Ludovica; McCubrey, James A.; Milella, Michele

Source: Current Signal Transduction Therapy, Volume 4, Number 2, May 2009 , pp. 130-143(14)

Publisher: Bentham Science Publishers

Molecular-targeted therapy in malignant melanoma

Authors: Sullivan, Ryan J; Atkins, Michael B

Source: Expert Review of Anticancer Therapy, Volume 9, Number 5, May 2009 , pp. 567-581(15)

Publisher: Expert Reviews

Molecular-targeted therapy in malignant melanoma

Authors: Sullivan, Ryan J; Atkins, Michael B

Source: Expert Review of Anticancer Therapy, Volume 9, Number 5, May 2009 , pp. 567-581(15)

Publisher: Expert Reviews

Selection of Patients with Hepatocellular Carcinoma for Sorafenib

Author: Abou-Alfa, Ghassan K.

Source: Journal of the National Comprehensive Cancer Network (JNCCN), Volume 7, Number 4, April 2009 , pp. 397-403(7)

Publisher: Cold Spring Publishing, LLC

Anti-angiogenic and vascular disrupting effects of C9, a new microtubule-depolymerizing agent

Authors: Ren, Xuan; Dai, Mei; Lin, Li-Ping; Li, Pui-Kai; Ding, Jian

Source: British Journal of Pharmacology, Volume 156, Number 8, April 2009 , pp. 1228-1238(11)

Publisher: Blackwell Publishing

Compartmentalized signalling: Ras proteins and signalling nanoclusters

Authors: Omerovic, Jasminka; Prior, Ian A.

Source: FEBS Journal, Volume 276, Number 7, April 2009 , pp. 1817-1825(9)

Publisher: Blackwell Publishing

Raf kinase inhibitor protein inhibits cell proliferation but promotes cell migration in rat hepatic stellate cells

Authors: Ma, Junji; Li, Fangfang; Liu, Li; Cui, Donglai; Wu, Xiaohui; Jiang, Xiaoyu; Jiang, Huiqing

Source: Liver International, Volume 29, Number 4, April 2009 , pp. 567-574(8)

Publisher: Blackwell Publishing

Sorafenib: A Review of its Use in Advanced Hepatocellular Carcinoma

Authors: Keating, Gillian M.; Santoro, Armando

Source: Drugs, Volume 69, Number 2, 2009 , pp. 223-240(18)

Publisher: Adis International